Moya F - Search Results

1

Moya F, Javier MC. Moya F, et al. Semin Fetal Neonatal Med. 2011 Oct;16(5):269-74. doi: 10.1016/j.siny.2011.03.006. Epub 2011 Apr 22. Semin Fetal Neonatal Med. 2011. PMID: 21515101 Review.

2

Animal-derived surfactants versus past and current synthetic surfactants: current status.

Moya F, Maturana A. Moya F, et al. Clin Perinatol. 2007 Mar;34(1):145-77, viii. doi: 10.1016/j.clp.2006.12.005. Clin Perinatol. 2007. PMID: 17394936 Review.

3

Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.

Moya F. Moya F. J Perinatol. 2009 May;29 Suppl 2:S23-8. doi: 10.1038/jp.2009.26. J Perinatol. 2009. PMID: 19399006 Review.

4

A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.

Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d'Agostino R; International Surfaxin Collaborative Study Group. Moya FR, et al. Pediatrics. 2005 Apr;115(4):1018-29. doi: 10.1542/peds.2004-2183. Pediatrics. 2005. PMID: 15805380 Clinical Trial.

5

Evidence-based management of infants with congenital diaphragmatic hernia.

Moya FR, Lally KP. Moya FR, et al. Semin Perinatol. 2005 Apr;29(2):112-7. doi: 10.1053/j.semperi.2005.05.007. Semin Perinatol. 2005. PMID: 16050529 Review.

6

Parental preferences regarding administration of an animal-derived versus a synthetic medication to newborn infants.

Sherman TI, Moya F, Simmons PD, Kurtz D, Shaffer TH. Sherman TI, et al. Among authors: moya f. J Neonatal Perinatal Med. 2016;9(1):7-14. doi: 10.3233/NPM-16915062. J Neonatal Perinatal Med. 2016. PMID: 27002267

7

One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.

Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G; SELECT and STAR Study Investigators. Moya F, et al. Pediatrics. 2007 Jun;119(6):e1361-70. doi: 10.1542/peds.2006-0149. Epub 2007 May 28. Pediatrics. 2007. PMID: 17533176 Clinical Trial.

8

A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.

Laughon M, Bose C, Moya F, Aschner J, Donn SM, Morabito C, Cummings JJ, Segal R, Guardia C, Liu G; Surfaxin Study Group. Laughon M, et al. Among authors: moya f. Pediatrics. 2009 Jan;123(1):89-96. doi: 10.1542/peds.2007-2680. Pediatrics. 2009. PMID: 19117865 Clinical Trial.

9

Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?

Sinha S, Moya F, Donn SM. Sinha S, et al. Among authors: moya f. Curr Opin Pediatr. 2007 Apr;19(2):150-4. doi: 10.1097/MOP.0b013e328082e2d9. Curr Opin Pediatr. 2007. PMID: 17496757 Review.

10

Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.

Lista G, Maturana A, Moya FR. Lista G, et al. Eur J Pediatr. 2017 Oct;176(10):1287-1293. doi: 10.1007/s00431-017-2984-y. Epub 2017 Aug 10. Eur J Pediatr. 2017. PMID: 28795220 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page